BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33154625)

  • 1. Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice.
    Moshfeghi A; Garmo V; Sheinson D; Ghanekar A; Abbass I
    Clin Ophthalmol; 2020; 14():3651-3659. PubMed ID: 33154625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice.
    Moshfeghi AA; Khurana RN; Moini H; Sherman S; Reed K; Boucher N; Rahimy E
    BMC Ophthalmol; 2024 May; 24(1):229. PubMed ID: 38822279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.
    Meer E; Bavinger JC; Yu Y; VanderBeek BL
    JAMA Ophthalmol; 2022 May; 140(5):529-532. PubMed ID: 35389455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study.
    Pidro A; Ahmedbegovic-Pjano M; Grisevic S; Sofic-Drino V; Gabric K; Biscevic A
    Mater Sociomed; 2019 Dec; 31(4):290-293. PubMed ID: 32082096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of choroidal thickness with diabetic retinopathy at different stages].
    Wang S; Lin S; Zheng Y; Di F; Cao X; Liu C; Yang J
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2584-8. PubMed ID: 26711604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
    Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
    JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.
    Li Y; Yu Y; VanderBeek BL
    Eye (Lond); 2020 May; 34(5):934-941. PubMed ID: 31586167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
    Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.
    Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
    PLoS One; 2016; 11(8):e0161897. PubMed ID: 27564383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
    Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
    Ophthalmol Retina; 2018 Jan; 2(1):38-45. PubMed ID: 31047300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.
    Lee CS; Lee AY; Baughman D; Sim D; Akelere T; Brand C; Crabb DP; Denniston AK; Downey L; Fitt A; Khan R; Mahmood S; Mandal K; Mckibbin M; Menon G; Lobo A; Kumar BV; Natha S; Varma A; Wilkinson E; Mitry D; Bailey C; Chakravarthy U; Tufail A; Egan C;
    Am J Ophthalmol; 2017 Aug; 180():64-71. PubMed ID: 28572062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome Changes Associated with the VEGFR Pathway and Immune System in Diabetic Macular Edema Patients at Different Diabetic Retinopathy Stages.
    Han R; Gong R; Liu W; Xu G
    Curr Eye Res; 2022 Jul; 47(7):1050-1060. PubMed ID: 35435079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
    Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
    Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory study of non-invasive, high-resolution functional macular imaging in subjects with diabetic retinopathy.
    Campagnoli TR; Somfai GM; Tian J; DeBuc DC; Smiddy WE
    Int J Ophthalmol; 2021; 14(1):57-63. PubMed ID: 33469484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-A novel OCT based imaging biomarker.
    Gupta C; Tan R; Mishra C; Khandelwal N; Raman R; Kim R; Agrawal R; Sen P
    PLoS One; 2018; 13(12):e0207435. PubMed ID: 30533048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of Close Follow-Up in Patients with Early-Grade Diabetic Retinopathy: A Taiwan Population-Based Study Grading via Deep Learning Model.
    Lee CC; Hsing SC; Lin YT; Lin C; Chen JT; Chen YH; Fang WH
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and the risk of progression to vision threatening diabetic retinopathy.
    Meer E; Bavinger JC; Yu Y; Hua P; McGeehan B; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):652-660. PubMed ID: 35253307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center--the Joslin Vision Network Eye Health Care Model.
    Cavallerano AA; Cavallerano JD; Katalinic P; Blake B; Rynne M; Conlin PR; Hock K; Tolson AM; Aiello LP; Aiello LM;
    Am J Ophthalmol; 2005 Apr; 139(4):597-604. PubMed ID: 15808153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
    Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
    JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.